Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (HBCUs) (UG3/UH3 Clinical Trial Not Allowed)
ID: 350542Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $300K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/350542

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-EB-23-006.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (HBCUs)." This initiative aims to enhance research capacity and educational infrastructure at HBCUs by supporting the development of biomedical engineering departments, interdisciplinary technology centers, and academic programs focused on addressing health disparities in underserved populations. The funding mechanism consists of a two-phase cooperative agreement, with Phase I (UG3) providing up to $300,000 annually for planning over three years, and Phase II (UH3) allowing up to $1 million per year for implementation over four years. Interested applicants must adhere to specific registration and submission requirements, with a closing date for applications set for September 30, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/rfa-files/RFA-EB-23-006.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-EB-23-006-Full-Announcement.html
    Please provide the text you would like summarized.
    RFA-EB-23-006.html
    The Department of Health and Human Services announces a funding opportunity aimed at enhancing biomedical research and educational infrastructure at Historically Black Colleges and Universities (HBCUs) through the Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) program. This initiative, led by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), seeks to build research capacity and technological innovation to address health disparities affecting underserved populations. The funding mechanism consists of a two-phase cooperative agreement: Phase I (UG3) allows up to $300,000 annually for planning over three years, while Phase II (UH3) permits up to $1 million per year for implementation over four years. Key application components include a detailed Milestone Plan, descriptions of institutional support, and a commitment to sustainable development. Eligible applicants are primarily HBCUs, with emphasis on promoting diversity in the biomedical workforce. The application process includes specific requirements for registrations, submissions via Grants.gov, and adherence to NIH policies on data management and sharing. Overall, this funding opportunity aims to leverage HBCUs' contributions to biomedical advancement and career preparation while fostering diversity within the scientific community.
    Similar Opportunities
    National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "National Centers for Biomedical Imaging and Bioengineering (NCBIB)" aimed at supporting the development and dissemination of new biomedical technologies. This initiative encourages applications from a diverse range of eligible entities, including higher education institutions and nonprofit organizations, to conduct technology research and development projects, collaborative projects, and service projects that address biomedical challenges. The program is designed to foster innovative research and enhance clinical applications, with funding typically ranging from $600,000 to $750,000 per project, and awards may last up to five years, with a total funding cap of fifteen years for any Center. Interested applicants should note that the application process opens on September 25, 2023, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov. For more details, please refer to the full announcement available at https://grants.nih.gov/grants/guide/pa-files/PAR-23-235.html.
    Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)" aimed at fostering collaborative research partnerships between academic and industrial investigators to accelerate the development of innovative bioengineering tools and technologies. The program seeks to establish multidisciplinary teams that apply a quantitative bioengineering approach to address significant biomedical challenges, with a focus on creating robust solutions that can enhance life science understanding and medical practices within a 5-10 year timeframe. Eligible applicants include a diverse range of organizations such as higher education institutions, nonprofits, and for-profit entities, particularly those emphasizing diversity in research. Interested parties should note that the application deadline is September 7, 2027, and for further inquiries, they can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information page at https://grants.nih.gov/grants/guide/pa-files/PAR-24-325.html.
    Notice of Intent to Publish a Funding Opportunity Announcement: Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at soliciting applications for research focused on developing biomedical technologies that address health disparities. This initiative seeks to support projects that create effective, affordable, and socially acceptable technologies to improve healthcare access and outcomes for underserved populations. The estimated total program funding for this opportunity is $1,200,000, with an expected two awards to be made, and the application process is anticipated to open in late 2025. Interested applicants can reach out to Nichole Daringer at nichole.daringer@nih.gov or call 301-451-4774 for further information.
    Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering funding through the Exploratory/Developmental Bioengineering Research Grants (EBRG) program, aimed at enhancing biomedical research and clinical care. This initiative encourages innovative applications that focus on developing new capabilities to address challenges in biomedical, preclinical, or clinical settings, with an emphasis on feasibility testing and novel methodologies. The program is particularly significant for advancing cancer research through innovative bioengineering approaches, welcoming proposals from a diverse range of eligible applicants, including universities, nonprofits, and small businesses, especially those representing underrepresented groups. The maximum budget for applicants is $275,000 over two years, with applications due by January 7, 2028. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-321.html.
    Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for the Focused Technology Research and Development (R01 Clinical Trial Not Allowed) grant, aimed at supporting innovative technology projects that advance biomedical research. Eligible applicants include a diverse range of institutions, such as Historically Black Colleges and Universities, Tribal Colleges, and various community-based organizations, with a focus on projects that demonstrate proof-of-concept and the development of working prototypes without integrating clinical trials. This initiative is crucial for fostering technological advancements that enhance understanding of biological processes, with no budget cap and a maximum project duration of five years. Interested applicants can find more information and application guidelines at NIH Grants, with proposals due by January 7, 2028.
    Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed), aimed at advancing innovative bioengineering solutions to address cancer and other biomedical challenges. This funding opportunity encourages projects that demonstrate the feasibility and potential utility of novel capabilities to enhance biomedical research, clinical care delivery, and accessibility, while specifically discouraging clinical trial proposals. Eligible applicants include a diverse range of institutions such as higher education entities, nonprofits, for-profit organizations, and foreign entities, with a funding cap of $275,000 available over a two-year period. Interested applicants can find more information and submission guidelines on the NIH website, with applications due by January 7, 2028. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Bioengineering Research, Innovation and Technology Education (BRITE) Program (R25 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Bioengineering Research, Innovation and Technology Education (BRITE) Program, a federal grant aimed at fostering the development of undergraduate students in bioengineering and related STEM fields. This program encourages private institutions of higher education to propose integrated educational activities that include a summer bridge program for incoming freshmen, academic year activities, and summer research experiences, ultimately guiding participants toward doctoral degrees or research careers in bioengineering and biomedical imaging. The BRITE Program is crucial for enhancing the capacity for rigorous bioengineering training and addressing the nation's health-related research needs. Interested applicants can contact Dr. Tina Gatlin at gatlincl@nih.gov or by phone at 240-731-3794, with the estimated project start date set for March 1, 2027, and the application window closing on May 11, 2026.
    NIGMS Institutional Biomedical Undergraduate Research Training Program
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIGMS Institutional Biomedical Undergraduate Research Training Program, a federal grant aimed at enhancing research training environments at institutions of higher education. This program seeks to develop a well-trained pool of undergraduate students who will transition into advanced biomedical research-focused degree programs, such as Ph.D. or M.D./Ph.D., by providing full-time support for 2-3 years of undergraduate biomedical research training. The initiative is particularly important for addressing the nation's biomedical, behavioral, and clinical research needs, especially at institutions with modest levels of NIH research project grant funding, including partnerships with community colleges. Interested applicants, specifically private institutions of higher education, can reach out to Behrous Davani, Ph.D., at behrous.davani@nih.gov or call 301-496-1058 for further information. The estimated synopsis close date is January 25, 2026, with an anticipated award date of October 1, 2026.
    Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE E/S)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE E/S)" aimed at enhancing biomedical research capacity in IDeA-eligible institutions. This program supports the expansion of research centers and the sustainability of existing infrastructures by encouraging institutions to grow their faculty base and develop research projects and core facilities in strategic scientific areas. The initiative is particularly significant for institutions in states that have historically received low levels of NIH funding, fostering advancements in health-related sciences. Interested applicants, specifically private institutions of higher education located in designated IDeA-eligible states, should prepare to submit their proposals by May 26, 2026, with an estimated award date of April 1, 2027. For further inquiries, contact Dr. Federico Bernal at federico.bernal@nih.gov or call 240-271-5059.
    IDeA Networks of Biomedical Research Excellence (INBRE)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "IDeA Networks of Biomedical Research Excellence (INBRE)" aimed at enhancing biomedical research capacity in states that have historically received low levels of NIH funding. This program seeks to support statewide networks consisting of research-intensive institutions and primarily undergraduate institutions (PUIs) in designated IDeA states, fostering collaboration, faculty research, student participation, and institutional research infrastructure development. Eligible applicants include private institutions of higher education located in specific states such as Alaska, Arkansas, and Puerto Rico, among others, with no cost-sharing or matching requirement. Interested parties can reach out to Dr. Jessica M. Faupel-Badger at 301-480-4969 or via email at badgerje@mail.nih.gov for further information. The estimated project start date is May 1, 2028, with applications closing on May 18, 2027.